title: Prenatal protein malnutrition enhances stimulus control by CDP, but not a CDP/THIP combination in rats.
abstract: In the present study, the effects of prenatal protein malnutrition on stimulus control exerted by the benzodiazepine (BZ), chlordiazepoxide (CDP) and the GABA-A receptor agonist 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol (THIP) were characterized. The adult, male offspring of female Sprague-Dawley rats fed either low (6% casein) or adequate (25% casein) protein diets 5 weeks prior to mating and throughout pregnancy served as subjects. Subjects were first trained to discriminate CDP (8.0 mg/kg ip) from saline using drug discrimination procedures. Once a criterion level of performance was achieved, generalization tests were performed to lower doses of CDP (4.0, 2.0, 1.0, 0.5 and 0.25 mg/kg) and then to several doses of THIP (10.0, 7.5, 5.6 and 3.2 mg/kg). Lastly, the ability of a single dose of THIP (3.0 mg/kg) to enhance discriminative control by several low doses of CDP (4.0, 2.0, 1.0 and 0.5 mg/kg) was assessed. Although both diet groups acquired the original CDP/saline discrimination at the same rate, malnourished rats exhibited significantly more generalization to low doses of CDP than their well-nourished counterparts. Neither diet group exhibited significant generalization to THIP nor a difference in THIP's ability to enhance the CDP cue. These results suggest that a subject's sensitivity to the stimulus properties of drugs can be selectively modified by prenatal malnutrition.
authors.affiliation: The Center for Behavioral Development and Mental Retardation, Boston University School of Medicine, M923 715 Albany Street, 02118, Boston, MA, USA
authors.forename: Penny L
authors.initials: PL
authors.lastname: Shultz
authors.forename: Janina R
authors.initials: JR
authors.lastname: Galler
authors.forename: John
authors.initials: J
authors.lastname: Tonkiss
mesh_terms: D000818:Animals; D002707:Chlordiazepoxide / Q000494:pharmacology*; D004044:Dietary Proteins; D004192:Discrimination, Psychological / Q000187:drug effects* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D004338:Drug Combinations; D005260:Female; D007555:Isoxazoles / Q000494:pharmacology*; D008297:Male; D010927:Placental Insufficiency / Q000523:psychology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D004044:Dietary Proteins; D004338:Drug Combinations; D007555:Isoxazoles; C026804:4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol; D002707:Chlordiazepoxide